Veracyte Inc
VCYT
$26.39-0.43 (-1.60%)
Jun 22, 2025, 4:00 PM
Financials
52Week High | 47.32 | 52Week Low | 19.73 |
Beta | 2.03 | Current Ratio Annual | 4.73 |
Current Ratio Quarterly | 5.10 | Gross Margin TTM | 68.02 |
Market Cap | 2.07B | Net Profit Margin TTM | 7.13 |
Operating Margin TTM | 5.11 | Price To Book | 1.73 |
Price To Earnings TTM | 62.54 | Price To Free Cash Flow TTM | 26.34 |
Price To Sales TTM | 4.46 | Quick Ratio Annual | 4.27 |
Quick Ratio Quarterly | 4.54 | Return On Assets TTM | 2.58 |
Return On Equity TTM | 2.83 | Return On Investment TTM | 2.82 |
Revenue Growth3Y | 26.64 | Revenue Growth5Y | 29.93 |
Revenue Growth Quarterly Yoy | 18.20 | Revenue Growth TTMYoy | 23.42 |
Revenue Per Share TTM | 5.79 |
Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 317 | 0 | 0 | 3 | 9 | 0 | 82.23M | $3.08B |
Mar 31, 2025 | 279 | 23 | 56 | 108 | 105 | 38 | 84.33M | $2.38B |
Change | 38(12%) | 23 | 56 | 105(3500%) | 96(1067%) | 38 | 2.10M(3%) | $697.84M(23%) |